| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,940 |
5,050 |
$210K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,104 |
1,031 |
$85K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,597 |
1,360 |
$73K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
960 |
907 |
$70K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
813 |
760 |
$69K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,532 |
2,414 |
$55K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,343 |
2,043 |
$53K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
722 |
652 |
$51K |
| 87428 |
|
791 |
714 |
$33K |
| S8301 |
Infection control supplies, not otherwise specified |
7,492 |
6,263 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,161 |
1,096 |
$16K |
| 92567 |
|
1,148 |
1,022 |
$13K |
| 97802 |
|
2,584 |
2,418 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
875 |
829 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
488 |
236 |
$6K |
| 90461 |
|
1,427 |
1,057 |
$6K |
| 87430 |
|
495 |
401 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
389 |
318 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
112 |
107 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
222 |
145 |
$2K |
| 90671 |
|
213 |
192 |
$2K |
| 96160 |
|
846 |
793 |
$2K |
| 81003 |
|
732 |
651 |
$1K |
| 97169 |
|
46 |
45 |
$1K |
| 90661 |
|
72 |
69 |
$1K |
| 92551 |
|
176 |
160 |
$327.01 |
| 90651 |
|
42 |
38 |
$269.14 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19 |
19 |
$233.81 |
| 87807 |
|
17 |
14 |
$111.10 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
366 |
299 |
$45.04 |
| 90686 |
|
566 |
544 |
$40.60 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
15 |
$26.83 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
136 |
115 |
$0.41 |
| 90619 |
|
97 |
93 |
$0.27 |
| 90697 |
|
115 |
110 |
$0.13 |
| 99401 |
|
1,930 |
1,862 |
$0.00 |
| 90670 |
|
490 |
462 |
$0.00 |
| 99173 |
|
265 |
254 |
$0.00 |
| 90707 |
|
66 |
63 |
$0.00 |
| 90648 |
|
42 |
39 |
$0.00 |
| 90633 |
|
168 |
159 |
$0.00 |
| 99072 |
|
123 |
109 |
$0.00 |
| 90734 |
|
24 |
24 |
$0.00 |
| 90715 |
|
17 |
13 |
$0.00 |
| 90710 |
|
91 |
91 |
$0.00 |
| 90680 |
|
257 |
243 |
$0.00 |
| 90716 |
|
64 |
61 |
$0.00 |
| 90723 |
|
16 |
15 |
$0.00 |
| 90696 |
|
44 |
44 |
$0.00 |